Heba A. Eassa
Impact in
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Drug Discovery top 10%
Papers in
-
- Advancements in Transdermal Drug Delivery 4
- Advanced Drug Delivery Systems 4
-
- Dermatology and Skin Diseases 2
- Co-authors
- Mohamed Ismail Nounou (6 shared papers)Ahmed Mohamed Fouad Amer (2 shared papers)Ivan O. Edafiogho (2 shared papers)Asmaa Saleh (1 shared paper)Hoda A. Salem (1 shared paper)Heba Ezzat Hashem (1 shared paper)Eman Samir Nossier (1 shared paper)Ahmed M. Naglah (1 shared paper)
- Journals
- International Journal of Applied Pharmaceutics (1 paper)Recent Patents on Drug Delivery & Formulation (1 paper)Current Pharmaceutical Design (1 paper)Molecules (1 paper)Pharmaceutical Development and Technology (1 paper)
- Partner nations
- EgyptUnited StatesSaudi Arabia
In The Last Decade
Heba A. Eassa
17 papers receiving 297 citations
Peers
Comparison fields: 5 of 95
- Pharmaceutical Science 89
- Drug Discovery 2
- Dermatology 33
- Biochemistry 13
- Molecular Medicine 10
Countries citing papers authored by Heba A. Eassa
This map shows the geographic impact of Heba A. Eassa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heba A. Eassa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heba A. Eassa more than expected).
Fields of papers citing papers by Heba A. Eassa
This network shows the impact of papers produced by Heba A. Eassa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heba A. Eassa. The network helps show where Heba A. Eassa may publish in the future.
Co-authors
The 14 scholars most cited alongside Heba A. Eassa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 109 | |
| 2 | 2022 | 54 | |
| 3 | 2021 | 34 | |
| 4 | 2019 | 26 | |
| 5 | 2023 | 19 | |
| 6 | 2019 | 18 | |
| 7 | 2022 | 11 | |
| 8 | Current Topical Strategies for Skin-Aging and Inflammaging Treatment: Science versus Fiction. | 2020 | 10 |
| 9 | 2020 | 8 | |
| 10 | 2021 | 6 | |
| 11 | 2023 | 4 | |
| 12 | 2024 | 2 | |
| 13 | 2024 | 2 | |
| 14 | 2023 | 2 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2022 | 1 |
About Heba A. Eassa
Heba A. Eassa is a scholar working on Pharmaceutical Science, Dermatology, Computational Theory and Mathematics, General Dentistry and Rehabilitation, having authored 17 papers that have together received 308 indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (4 papers), Advanced Drug Delivery Systems (4 papers), Computational Drug Discovery Methods (3 papers), Dermatology and Skin Diseases (2 papers), Infection Control and Ventilation (1 paper), Enzyme Catalysis and Immobilization (1 paper), Protein purification and stability (1 paper) and COVID-19 diagnosis using AI (1 paper). The work is most often cited by research in Pharmaceutical Science (89 citations), Drug Discovery (2 citations), Dermatology (33 citations), Biochemistry (13 citations) and Molecular Medicine (10 citations). Heba A. Eassa has collaborated with scholars based in Egypt, United States and Saudi Arabia. Frequent co-authors include Mohamed Ismail Nounou, Ahmed Mohamed Fouad Amer, Ivan O. Edafiogho, Asmaa Saleh, Hoda A. Salem, Heba Ezzat Hashem, Eman Samir Nossier, Ahmed M. Naglah, Abdulrahman Abdulaziz Almehizia and Abd El‐Galil E. Amr. Their work appears in journals such as International Journal of Applied Pharmaceutics, Recent Patents on Drug Delivery & Formulation, Current Pharmaceutical Design, Molecules and Pharmaceutical Development and Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.